FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 342-348

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy of Non-small Cell Lung Cancer in Elderly Patients

By  

Current Medicinal Chemistry, Vol. 9, Iss. 16, 2002-08 ,pp. : 1487-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination

By Esteban-Gonzalez Emilio   Fernández Yolanda   Villanueva Noemí   Fra Joaquin   Muñiz Isabel   Palacio Isabel   Vieitez Jose   Uña Esther   Mareque Beatriz   Lacave Angel  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 597-601

Springer Publishing Company

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.  

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite